Two landmark randomized controlled trials, the North American Symptomatic Carotid Endarterectomy Trial (NASCET) 1 and the European Carotid Surgery Trial (ECST), 2 demonstrated the relative benefit of carotid endarterectomy (CEA) performed within 6 months of an ipsilateral cerebrovascular event (transient ischemic attack [TIA] or stroke) compared to medical treatment for patients with 70% to 99% carotid artery stenosis. Based on these findings, the 1998 American Heart Association (AHA) guidelines recommended CEA for the management of patients with a 70% to 99% carotid artery stenosis and a recent (<6 months) ipsilateral nondisabling carotid artery ischemic event (grade A recommendation). 3 The general belief at that time was that CEA should be delayed for 6 to 8 weeks after a TIA/ischemic stroke because (a) there was an increased risk of hemorrhagic transformation of the infarct, (b) early surgery was thought to be associated with an increased rate of complications, and (c) the risk of having a stroke in the first few weeks after presentation was not considered to be high. 4 It was further thought that a slight delay would probably be beneficial for the patient (as it would stabilize the unstable carotid plaque). 4 A reanalysis of pooled data from NASCET and ECST (n ¼ 5893 patients; 33 000 patient-years of follow-up), however, showed that the benefit from CEA was the greatest in patients randomized within 2 weeks after their last ischemic event and fell rapidly with increasing delay. 5 In male patients with 70% carotid stenosis, the 5-year absolute risk reduction in ipsilateral ischemic stroke with CEA was 30.2% for men randomized within 2 weeks of their last event (number needed to treat [NNT] with CEA to prevent 1 ipsilateral stroke ¼ 3), whereas it was reduced by half for males randomized 2 to 4 weeks after their last event (NNT ¼ 6) and it was reduced even further in men randomized after 4 weeks (NNT ¼ 9). For females, the benefit of CEA for 70% stenosis was seen only if they underwent CEA within 2 weeks of symptoms and not later. Importantly, these results were consistent across the individual trials. 5 Furthermore, there was no association between perioperative risk of stroke or death and time since the last ischemic event. 5 These results verified and extended the results of an earlier NASCET subgroup analysis, which showed that stroke and death rates in symptomatic patients undergoing early (<30 days) CEA did not differ from those undergoing late (>30 days) CEA (relative risk: 0.92; 95% confidence interval [CI]: 0.16-5.27; P ¼ 1.00). guidelines revised their recommendations. Both guidelines indicated that in symptomatic patients, performance of CEA within 2 weeks is reasonable unless otherwise contraindicated. 7, 8 This recommendation referred to patients having experienced a recent neurologic event and who were at average or low surgical risk.
A subgroup of symptomatic patients who may be at higher stroke risk if operated on urgently are those patients with crescendo TIA and stroke-in-evolution. Three systematic reviews have demonstrated that patients with unstable neurologic presentations (crescendo TIA and stroke-in-evolution) are at higher risk of complications if operated on urgently compared to symptomatic patients with stable symptoms. [9] [10] [11] Nevertheless, urgent CEA may be justified even in these patients due to the high rate of recurrent events if they do not undergo CEA. 4 The recommendations of the UK National Stroke Strategy 12 were more aggressive than the other guidelines. 7, 8 Intervention for symptomatic severe carotid stenosis was recommended within 2 days in neurologically stable patients. In contrast, the benefit of very early CEA was questioned by the Swedish Vascular Registry. 13 This study analyzed the outcomes of all symptomatic patients undergoing CEA between May 12, 2008 and May 31, 2011, and divided the outcomes according to time between the qualifying event and CEA (0-2, 3-7, 8-14, and 15-180 days). The combined mortality and stroke rates for patients treated very urgently were considerably higher compared to those treated later (11.5% for patients undergoing CEA 0-2 days after the qualifying event vs 3.6%, 4.0%, and 5.4% for patients undergoing CEA 3-7, 8-14, and 15-180 days after the event, respectively). Patients treated very urgently had >4-fold higher stroke/death rates compared to patients operated on 3 to 7 days after the event (odds ratio [OR]: 4.24; 95% CI: 2.07-8.70; P < .001). 13 A possible explanation for these high stroke rates may be that nearly 12% of the patients in the group undergoing very urgent CEA presented with crescendo TIAs. 14 As mentioned earlier, these patients are at higher risk of complications if operated on urgently. [9] [10] [11] An international multicenter study recently reported that the stroke risk associated with CEA in symptomatic patients does not differ when the procedure is performed within 2 days versus within 2 weeks from symptom onset. 15 Patients were divided into 2 groups-those who underwent urgent CEA (0-2 days after symptom onset; n ¼ 20) and those who underwent early CEA (3-14 days after symptom onset; n ¼ 145). The 30-day stroke rate in patients who underwent urgent CEA was similar to the stroke rates in patients who underwent early CEA (10.0% vs 4.1%; P ¼ .260). 15 These results were verified in another recent, independent report presenting the outcomes of 761 symptomatic patients undergoing CEA within 4 different timing groups. 16 The stroke and death rates for the 4 groups were 4.4% (9 of 206), 1.8% (4 of 219), 4.4% (6 of 136), and 2.5% (5 of 200) for CEA performed within 0 to 2, 3 to 7, 8 to 14, and >14 days, respectively (P ¼ .25 for the difference between the groups). Furthermore, the timing of surgery did not influence the perioperative outcome in multivariate regression analysis (OR: 0.93; 95% CI: 0.63-1.36; P ¼ .71). 16 An interesting finding is that urgent (rather than delayed) CEA is more beneficial for patients even if intervening early is associated with a procedural risk as high as 10%. A reanalysis of pooled data from NASCET, 1 ECST, 2 and the Veterans Affairs trial 17 suggests that a surgeon who operates within 2 weeks with a 10% stroke risk will actually prevent more strokes at 5 years than a surgeon who waits 4 weeks and who then operates with a 0% stroke risk. 18 This analysis provides proof that the increased stroke risk associated with urgent CEA is considerably less when compared to the risk of having a recurrent stroke by delaying CEA. 18 Encouraging results were recently reported by the UK National Vascular Registry. 19 An analysis of 23 235 CEAs performed in the United Kingdom from January 2009 to December 2014 showed that the time from onset of neurological symptoms (TIA/stroke) to undergoing CEA has decreased year on year. Although CEA was performed within 2 weeks of index symptom onset in only 10% of patients in 2008, it increased to 37% in 2009 and went up to 58% by 2014. Performing CEA within 48 hours of symptom onset was associated with a small increase in the 30-day stroke and death rate (3.1% vs 2.0%, for 0-2 vs 3-7 days, respectively; adjusted OR: 1.64; 95% CI: 1.04-2.59) but not with longer delays. Nevertheless, this risk is still within the recommended threshold/risk and is perfectly acceptable. The disappointing news is that around 40% of symptomatic patients undergoing CEA in the United Kingdom in 2014 did not undergo their operation within 14 days. The most common reason for this was a delay in referral to the vascular surgeon followed by a delay in the patient seeking medical advice and delays in accessing carotid imaging. 19 In conclusion, the management of patients with symptomatic carotid artery stenosis has undergone considerable changes in the last few years. 20 Previously conceived myths and fallacies have been proven wrong, and international guidelines have been revised accordingly. Current evidence dictates that CEA should be performed within 2 weeks of a TIA/stroke. Despite the earlier general assumption that urgent CEA is associated with increased periprocedural stroke risk, it is now proven that this is a flawed misconception. 5, 6, 15, 16 All physicians involved in the management of patients with stroke (eg, vascular surgeons, neurologists, stroke physicians, general practitioners, ultrasonographers, etc) should be aware of the benefits associated with urgent CEA and should make sure that patients with symptomatic carotid are referred to and operated on as soon as possible following a TIA/stroke.
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